As of December 2024 Amphastar Pharmaceuticals has a market cap of HK$15.26 Billion. This makes Amphastar Pharmaceuticals the world's 4376th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2024 | HK$15.26 B | -34.04% |
2023 | HK$23.14 B | 118.71% |
2022 | HK$10.58 B | 21.77% |
2021 | HK$8.68 B | 17.36% |
2020 | HK$7.40 B | 5.82% |
2019 | HK$6.99 B | -3.71% |
2018 | HK$7.26 B | 5.15% |
2017 | HK$6.91 B | 5.13% |
2016 | HK$6.57 B | 31.87% |
2015 | HK$4.98 B | 23.99% |
2014 | HK$4.02 B |
On Dec 16th, 2024 the market cap of Amphastar Pharmaceuticals was reported to be: